To validate the association between BACH1 and p53 in GBM patients, data from 90 GBM patients receiving TMZ therapy in the TCGA database that contained integrated survival information were selected for Kaplan–Meier survival curve analysis. This evidence concerns the gene BACH1 and glioblastoma.